Gene,rsId,Ref,Alt,Effect,Alleles Frequency,Number of citation,Publications,Clinical Significant,ClinVar Accession,Cytogenetic location,Variant name,Disease name,Synonyms
CBL,rs267606704,A,C,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000009 (1/113632, ExAC).C=0.00001 (1/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs267606704,Pathogenic,RCV000014818.25,11q23.3,NM_005188.4(CBL):c.1100A>C (p.Gln367Pro),"Fragile site 11b (FRA11B)
                    ",MedGen: CN296118; OMIM: 600651
CBL,rs267606704,A,C,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000009 (1/113632, ExAC).C=0.00001 (1/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs267606704,Pathogenic,RCV000033352.12,11q23.3,NM_005188.4(CBL):c.1100A>C (p.Gln367Pro),none provided,MedGen: CN517202
CBL,rs267606704,A,C,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000009 (1/113632, ExAC).C=0.00001 (1/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs267606704,Pathogenic,RCV000702464.7,11q23.3,NM_005188.4(CBL):c.1100A>C (p.Gln367Pro),RASopathy,rasopathies; Noonan spectrum disorder
CBL,rs267606704,A,C,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000009 (1/113632, ExAC).C=0.00001 (1/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs267606704,Likely-Pathogenic,RCV001266923.1,11q23.3,NM_005188.4(CBL):c.1100A>C (p.Gln367Pro),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
CBL,rs267606704,A,C,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000009 (1/113632, ExAC).C=0.00001 (1/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs267606704,Pathogenic,RCV001353389.2,11q23.3,NM_005188.4(CBL):c.1100A>C (p.Gln367Pro),CBL-related disorder,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; CBL MUTATION-ASSOCIATED SYNDROME; CBL SYNDROME; See all synonyms [MedGen]
CBL,rs267606704,A,C,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.000009 (1/113632, ExAC).C=0.00001 (1/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs267606704,Pathogenic,RCV001813204.1,11q23.3,NM_005188.4(CBL):c.1100A>C (p.Gln367Pro),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
CBL,rs267606705,A,G,"missense_variant,coding_sequence_variant","G=0.00000 (0/78696, PAGE_STUDY).G=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267606705,Pathogenic,RCV000014819.26,11q23.3,NM_005188.4(CBL):c.1144A>G (p.Lys382Glu),"Fragile site 11b (FRA11B)
                    ",MedGen: CN296118; OMIM: 600651
CBL,rs267606705,A,G,"missense_variant,coding_sequence_variant","G=0.00000 (0/78696, PAGE_STUDY).G=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267606705,Likely-Pathogenic,RCV001268437.1,11q23.3,NM_005188.4(CBL):c.1144A>G (p.Lys382Glu),none provided,MedGen: C3661900
CBL,rs267606706,T,A,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Likely-Pathogenic,RCV000506397.6,11q23.3,NM_005188.4(CBL):c.1111T>A (p.Tyr371Asn),AllHighlyPenetrant,MedGen: CN169374
CBL,rs267606706,T,A,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Pathogenic,RCV000856726.1,11q23.3,NM_005188.4(CBL):c.1111T>A (p.Tyr371Asn),"Noonan syndrome 1 (NS1)
                    ","Turner Syndrome, Male; Turner phenotype with normal karyotype; Female pseudo-Turner syndrome"
CBL,rs267606706,T,A,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Likely-Pathogenic,RCV001814073.2,11q23.3,NM_005188.4(CBL):c.1111T>A (p.Tyr371Asn),CBL-related disorder,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; CBL MUTATION-ASSOCIATED SYNDROME; CBL SYNDROME; See all synonyms [MedGen]
CBL,rs267606706,T,A,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Pathogenic,RCV002277316.1,11q23.3,NM_005188.4(CBL):c.1111T>A (p.Tyr371Asn),Neurodevelopmental disorder,MONDO: MONDO:0700092; MeSH: D065886; MedGen: C1535926
CBL,rs267606706,T,C,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Pathogenic,RCV000014822.25,11q23.3,NM_005188.4(CBL):c.1111T>C (p.Tyr371His),Noonan syndrome-like disorder with juvenile myelomonocytic leukemia,MedGen: C4016301
CBL,rs267606706,T,C,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Likely-Pathogenic,RCV000437548.1,11q23.3,NM_005188.4(CBL):c.1111T>C (p.Tyr371His),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
CBL,rs267606706,T,C,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Pathogenic,RCV000441724.4,11q23.3,NM_005188.4(CBL):c.1111T>C (p.Tyr371His),none provided,MedGen: CN517202
CBL,rs267606706,T,C,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Pathogenic,RCV000691502.4,11q23.3,NM_005188.4(CBL):c.1111T>C (p.Tyr371His),RASopathy,rasopathies; Noonan spectrum disorder
CBL,rs267606706,T,C,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Pathogenic,RCV001527385.2,11q23.3,NM_005188.4(CBL):c.1111T>C (p.Tyr371His),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
CBL,rs267606706,T,C,"missense_variant,coding_sequence_variant","C=0.000008 (2/250954, GnomAD_exome).C=0.000007 (1/140266, GnomAD).C=0.000017 (2/118126, ExAC)",4,https://www.ncbi.nlm.nih.gov/snp/rs267606706,Pathogenic,RCV002274879.1,11q23.3,NM_005188.4(CBL):c.1111T>C (p.Tyr371His),See cases [See the Variation display for details],
CBL,rs267606707,G,T,"missense_variant,coding_sequence_variant","T=0.00000 (0/78700, PAGE_STUDY).T=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267606707,Pathogenic,RCV000014820.25,11q23.3,NM_005188.4(CBL):c.1168G>T (p.Asp390Tyr),"Fragile site 11b (FRA11B)
                    ",MedGen: CN296118; OMIM: 600651
CBL,rs267606708,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251418, GnomAD_exome).A=0.000021 (3/140170, GnomAD).A=0.000008 (1/123208, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267606708,Pathogenic,RCV000014821.26,11q23.3,NM_005188.4(CBL):c.1259G>A (p.Arg420Gln),"Fragile site 11b (FRA11B)
                    ",MedGen: CN296118; OMIM: 600651
CBL,rs267606708,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251418, GnomAD_exome).A=0.000021 (3/140170, GnomAD).A=0.000008 (1/123208, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267606708,Pathogenic,RCV000414703.1,11q23.3,NM_005188.4(CBL):c.1259G>A (p.Arg420Gln),none provided,MedGen: CN517202
CBL,rs267606708,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251418, GnomAD_exome).A=0.000021 (3/140170, GnomAD).A=0.000008 (1/123208, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267606708,Pathogenic,RCV001257538.1,11q23.3,NM_005188.4(CBL):c.1259G>A (p.Arg420Gln),Rhabdomyosarcoma,Rhabdomyosarcoma (disease)
CBL,rs267606708,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251418, GnomAD_exome).A=0.000021 (3/140170, GnomAD).A=0.000008 (1/123208, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs267606708,Likely-Pathogenic,RCV001705593.3,11q23.3,NM_005188.4(CBL):c.1259G>A (p.Arg420Gln),CBL-related disorder,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; CBL MUTATION-ASSOCIATED SYNDROME; CBL SYNDROME; See all synonyms [MedGen]
CBL,rs387906664,T,C,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs387906664,Pathogenic,RCV000022698.22,11q23.3,NM_005188.4(CBL):c.1150T>C (p.Cys384Arg),Noonan syndrome-like disorder with juvenile myelomonocytic leukemia,MedGen: C4016301
CBL,rs387906664,T,C,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs387906664,Likely-Pathogenic,RCV000420743.1,11q23.3,NM_005188.4(CBL):c.1150T>C (p.Cys384Arg),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
CBL,rs387906664,T,C,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs387906664,Pathogenic,RCV001561040.2,11q23.3,NM_005188.4(CBL):c.1150T>C (p.Cys384Arg),none provided,MedGen: CN517202
CBL,rs387906665,T,C,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).C=0.000016 (2/121324, ExAC).A=0.00000 (0/14528, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387906665,Pathogenic,RCV000022699.22,11q23.3,NM_005188.4(CBL):c.1186T>C (p.Cys396Arg),Noonan syndrome-like disorder with juvenile myelomonocytic leukemia,MedGen: C4016301
CBL,rs387906665,T,C,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).C=0.000016 (2/121324, ExAC).A=0.00000 (0/14528, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387906665,Pathogenic,RCV000157860.1,11q23.3,NM_005188.4(CBL):c.1186T>C (p.Cys396Arg),none provided,MedGen: C3661900
CBL,rs387906666,A,C,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387906666,Pathogenic-Likely-Pathogenic,RCV000660642.3,11q23.3,NM_005188.4(CBL):c.1112A>C (p.Tyr371Ser),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
CBL,rs387906666,A,G,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387906666,Pathogenic,RCV000022700.30,11q23.3,NM_005188.4(CBL):c.1112A>G (p.Tyr371Cys),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
CBL,rs387906666,A,G,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387906666,Pathogenic,RCV000211127.3,11q23.3,NM_005188.4(CBL):c.1112A>G (p.Tyr371Cys),Noonan syndrome-like disorder with juvenile myelomonocytic leukemia,MedGen: C4016301
CBL,rs727504504,C,A,"coding_sequence_variant,stop_gained,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs727504504,Likely-Pathogenic,RCV000155642.4,11q23.3,NM_005188.4(CBL):c.1099C>A (p.Gln367Lys),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
CBL,rs727504640,G,T,"coding_sequence_variant,missense_variant","A=0.00007 (3/41048, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs727504640,Likely-Pathogenic,RCV000492503.1,11q23.3,NM_005188.4(CBL):c.1754G>T (p.Arg585Leu),CBL-related disorder,Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia; CBL MUTATION-ASSOCIATED SYNDROME; CBL SYNDROME; See all synonyms [MedGen]
CD70,rs1568431102,AAG,delAAG,"coding_sequence_variant,inframe_deletion,intron_variant",None,non citation,,Pathogenic,RCV000735977.3,19p13.3,NM_001252.5(CD70):c.552CTT[1] (p.Phe186del),Severe combined immunodeficiency due to CD70 deficiency,LYMPHOPROLIFERATIVE SYNDROME 3; CD70 DEFICIENCY
CDC73,rs28942098,G,A,"initiator_codon_variant,missense_variant","A=0.00000 (0/78698, PAGE_STUDY).A=0.0000 (0/1814, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs28942098#publications,Pathogenic,RCV000003424.3,1q31.2,NM_024529.5(CDC73):c.3G>A (p.Met1Ile),Hyperparathyroidism 2 with jaw tumors,"HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS; HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY; Hyperparathyroidism 2"
CDC73,rs28942098,G,T,"initiator_codon_variant,missense_variant","A=0.00000 (0/78698, PAGE_STUDY).A=0.0000 (0/1814, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs28942098#publications,Pathogenic,RCV000579066.1,1q31.2,NM_024529.5(CDC73):c.3G>T (p.Met1Ile),none provided,MedGen: CN517202
CDC73,rs121434262,C,T,"stop_gained,coding_sequence_variant,synonymous_variant","A=0.000004 (1/251440, GnomAD_exome).T=0.00001 (1/78696, PAGE_STUDY).T=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434262,Pathogenic,RCV000003425.3,1q31.2,NM_024529.5(CDC73):c.25C>T (p.Arg9Ter),Hyperparathyroidism 2 with jaw tumors,"HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS; HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY; Hyperparathyroidism 2"
CDC73,rs121434264,T,C,"coding_sequence_variant,missense_variant","C=0.00000 (0/78692, PAGE_STUDY).C=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434264,Pathogenic,RCV000003431.3,1q31.2,NM_024529.5(CDC73):c.191T>C (p.Leu64Pro),"Hyperparathyroidism 1 (HRPT1)
                    ","HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY"
CDC73,rs121434264,T,C,"coding_sequence_variant,missense_variant","C=0.00000 (0/78692, PAGE_STUDY).C=0.000 (0/660, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121434264,Likely-Pathogenic,RCV001851616.3,1q31.2,NM_024529.5(CDC73):c.191T>C (p.Leu64Pro),"Parathyroid carcinoma (PRTC)
                    ",Parathyroid cancer; CDC73-Related Parathyroid Carcinoma
CDC73,rs121434265,C,G,"stop_gained,coding_sequence_variant,synonymous_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121434265,Pathogenic,RCV000003433.6,1q31.2,NM_024529.5(CDC73):c.162C>G (p.Tyr54Ter),"Parathyroid carcinoma (PRTC)
                    ",Parathyroid cancer; CDC73-Related Parathyroid Carcinoma
CDC73,rs587776561,CTTAGCGTCCTGCGACAG,delCTTAGCGTCCTGCGACAG,"inframe_deletion,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587776561,Pathogenic,RCV000003442.5,1q31.2,NM_024529.5(CDC73):c.13_30del (p.Leu5_Gln10del),"Parathyroid carcinoma (PRTC)
                    ",Parathyroid cancer; Parathyroid gland carcinoma; CDC73-Related Parathyroid Carcinoma
CDH1,rs33935154,G,A,"5_prime_UTR_variant,missense_variant,coding_sequence_variant","A=0.014409 (3814/264690, TOPMED).A=0.001376 (313/227422, ALFA).A=0.014120 (1979/140160, GnomAD)",11,https://www.ncbi.nlm.nih.gov/snp/rs33935154#publications,Pathogenic,RCV000013018.6,16q22.1,NM_004360.5(CDH1):c.1849G>A (p.Ala617Thr),Endometrial carcinoma,"Endometrial carcinoma, somatic"
CDH1,rs35572355,G,A,"missense_variant,coding_sequence_variant","A=0.000053 (14/264690, TOPMED).A=0.000208 (35/168534, ALFA).A=0.000043 (6/140194, GnomAD)",5,https://www.ncbi.nlm.nih.gov/snp/rs35572355,Likely-Pathogenic,RCV000148456.2,16q22.1,NM_004360.5(CDH1):c.2494G>A (p.Val832Met),Neoplasm of stomach,Neoplasm of the stomach; Gastric neoplasm; Stomach Neoplasms
CDH1,rs121964871,C,G,"missense_variant,synonymous_variant,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000004 (1/250252, GnomAD_exome).G=0.000021 (3/140194, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964871,Pathogenic,RCV000013017.5,16q22.1,NM_004360.5(CDH1):c.2131C>G (p.Leu711Val),Endometrial carcinoma,"Endometrial carcinoma, somatic"
CDH1,rs121964872,A,G,"missense_variant,coding_sequence_variant","G=0.000106 (28/264690, TOPMED).G=0.000044 (11/251492, GnomAD_exome).G=0.000190 (36/189600, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121964872,Pathogenic,RCV000013020.5,16q22.1,NM_004360.5(CDH1):c.2512A>G (p.Ser838Gly),Neoplasm of ovary,"Ovarian tumor; OVARIAN CANCER, SOMATIC; Ovarian neoplasm; See all synonyms [MedGen]"
CDH1,rs121964873,G,T,"stop_gained,5_prime_UTR_variant,coding_sequence_variant,missense_variant","A=0.000012 (3/251458, GnomAD_exome).A=0.000008 (1/121406, ExAC).A=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964873,Pathogenic,RCV000013021.6,16q22.1,NM_004360.5(CDH1):c.781G>T (p.Glu261Ter),Breast lobular carcinoma,"Breast cancer, lobular; BREAST CANCER, LOBULAR, SOMATIC"
CDH1,rs121964873,G,T,"stop_gained,5_prime_UTR_variant,coding_sequence_variant,missense_variant","A=0.000012 (3/251458, GnomAD_exome).A=0.000008 (1/121406, ExAC).A=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964873,Pathogenic,RCV000991090.5,16q22.1,NM_004360.5(CDH1):c.781G>T (p.Glu261Ter),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs121964874,C,T,"stop_gained,missense_variant,coding_sequence_variant","A=0.000004 (1/251268, GnomAD_exome).A=0.000008 (1/121226, ExAC).T=0.00000 (0/78702, PAGE_STUDY)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964874,Pathogenic,RCV000013024.28,16q22.1,NM_004360.5(CDH1):c.2095C>T (p.Gln699Ter),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs121964875,G,A,"stop_gained,5_prime_UTR_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121964875,Pathogenic,RCV000013026.23,16q22.1,NM_004360.5(CDH1):c.59G>A (p.Trp20Ter),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs121964876,G,T,"stop_gained,5_prime_UTR_variant,coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121964876,Pathogenic,RCV000013027.27,16q22.1,NM_004360.5(CDH1):c.70G>T (p.Glu24Ter),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs121964877,C,T,"stop_gained,5_prime_UTR_variant,coding_sequence_variant,missense_variant","T=0.00000 (0/78702, PAGE_STUDY).T=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121964877,Pathogenic,RCV000013028.33,16q22.1,NM_004360.5(CDH1):c.1792C>T (p.Arg598Ter),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs121964877,C,T,"stop_gained,5_prime_UTR_variant,coding_sequence_variant,missense_variant","T=0.00000 (0/78702, PAGE_STUDY).T=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121964877,Pathogenic,RCV000213248.3,16q22.1,NM_004360.5(CDH1):c.1792C>T (p.Arg598Ter),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDH1,rs121964877,C,T,"stop_gained,5_prime_UTR_variant,coding_sequence_variant,missense_variant","T=0.00000 (0/78702, PAGE_STUDY).T=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121964877,Pathogenic,RCV000484230.6,16q22.1,NM_004360.5(CDH1):c.1792C>T (p.Arg598Ter),none provided,MedGen: CN517202
CDH1,rs121964878,C,T,"5_prime_UTR_variant,coding_sequence_variant,missense_variant","T=0.00005 (1/21858, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964878,Likely-Pathogenic,RCV000013031.33,16q22.1,NM_004360.5(CDH1):c.1901C>T (p.Ala634Val),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs121964878,C,T,"5_prime_UTR_variant,coding_sequence_variant,missense_variant","T=0.00005 (1/21858, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964878,Pathogenic,RCV001013619.3,16q22.1,NM_004360.5(CDH1):c.1901C>T (p.Ala634Val),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDH1,rs121964878,C,T,"5_prime_UTR_variant,coding_sequence_variant,missense_variant","T=0.00005 (1/21858, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964878,Pathogenic,RCV001778650.2,16q22.1,NM_004360.5(CDH1):c.1901C>T (p.Ala634Val),Malignant tumor of breast,Malignant breast neoplasm; Cancer breast
CDH1,rs121964878,C,T,"5_prime_UTR_variant,coding_sequence_variant,missense_variant","T=0.00005 (1/21858, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121964878,Likely-Pathogenic,RCV001781253.2,16q22.1,NM_004360.5(CDH1):c.1901C>T (p.Ala634Val),none provided,MedGen: CN517202
CDH1,rs149127230,G,T,"missense_variant,coding_sequence_variant,stop_gained","A=0.000529 (140/264690, TOPMED).A=0.000119 (23/193894, ALFA).A=0.000578 (81/140196, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs149127230,Pathogenic,RCV000530851.5,16q22.1,NM_004360.5(CDH1):c.2104G>T (p.Glu702Ter),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs267606712,G,A,"synonymous_variant,coding_sequence_variant,5_prime_UTR_variant,missense_variant","T=0.00001 (1/78342, PAGE_STUDY).T=0.000 (0/660, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267606712,Pathogenic,RCV000217412.2,16q22.1,NM_004360.5(CDH1):c.1008G>A (p.Glu336=),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDH1,rs267606712,G,A,"synonymous_variant,coding_sequence_variant,5_prime_UTR_variant,missense_variant","T=0.00001 (1/78342, PAGE_STUDY).T=0.000 (0/660, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267606712,Likely-Pathogenic,RCV000639283.6,16q22.1,NM_004360.5(CDH1):c.1008G>A (p.Glu336=),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs267606712,G,T,"synonymous_variant,coding_sequence_variant,5_prime_UTR_variant,missense_variant","T=0.00001 (1/78342, PAGE_STUDY).T=0.000 (0/660, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267606712,Likely-Pathogenic,RCV000013022.19,16q22.1,NM_004360.5(CDH1):c.1008G>T (p.Glu336Asp),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs267606712,G,T,"synonymous_variant,coding_sequence_variant,5_prime_UTR_variant,missense_variant","T=0.00001 (1/78342, PAGE_STUDY).T=0.000 (0/660, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267606712,Pathogenic,RCV000572541.1,16q22.1,NM_004360.5(CDH1):c.1008G>T (p.Glu336Asp),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDH1,rs587780537,G,A,"5_prime_UTR_variant,missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs587780537,Pathogenic,RCV000119150.12,16q22.1,NM_004360.5(CDH1):c.715G>A (p.Gly239Arg),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs587780537,G,A,"5_prime_UTR_variant,missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs587780537,Pathogenic-Likely-Pathogenic,RCV000160387.8,16q22.1,NM_004360.5(CDH1):c.715G>A (p.Gly239Arg),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDH1,rs587780537,G,A,"5_prime_UTR_variant,missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs587780537,Pathogenic-Likely-Pathogenic,RCV000507875.5,16q22.1,NM_004360.5(CDH1):c.715G>A (p.Gly239Arg),none provided,MedGen: CN517202
CDH1,rs587783050,G,A,"synonymous_variant,5_prime_UTR_variant,coding_sequence_variant","A=0.000008 (2/264690, TOPMED).A=0.00000 (0/14050, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs587783050,Pathogenic,RCV000013036.27,16q22.1,NM_004360.5(CDH1):c.1137G>A (p.Thr379=),"Gastric cancer, familial diffuse, and cleft lip with or without cleft palate","GASTRIC CANCER, HEREDITARY DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE"
CDH1,rs587783050,G,A,"synonymous_variant,5_prime_UTR_variant,coding_sequence_variant","A=0.000008 (2/264690, TOPMED).A=0.00000 (0/14050, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs587783050,Pathogenic,RCV000144593.11,16q22.1,NM_004360.5(CDH1):c.1137G>A (p.Thr379=),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDH1,rs587783050,G,A,"synonymous_variant,5_prime_UTR_variant,coding_sequence_variant","A=0.000008 (2/264690, TOPMED).A=0.00000 (0/14050, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs587783050,Pathogenic,RCV000162417.5,16q22.1,NM_004360.5(CDH1):c.1137G>A (p.Thr379=),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDH1,rs587783050,G,A,"synonymous_variant,5_prime_UTR_variant,coding_sequence_variant","A=0.000008 (2/264690, TOPMED).A=0.00000 (0/14050, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs587783050,Pathogenic,RCV000520174.3,16q22.1,NM_004360.5(CDH1):c.1137G>A (p.Thr379=),none provided,MedGen: CN517202
CDH1,rs587783050,G,T,"synonymous_variant,5_prime_UTR_variant,coding_sequence_variant","A=0.000008 (2/264690, TOPMED).A=0.00000 (0/14050, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs587783050,Likely-Pathogenic,RCV000736290.2,16q22.1,NM_004360.5(CDH1):c.1137G>T (p.Thr379=),Hereditary diffuse gastric adenocarcinoma,"Hereditary diffuse gastric cancer; DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR"
CDK4,rs11547328,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Pathogenic,RCV000018436.4,12q14.1,NM_000075.4(CDK4):c.70C>T (p.Arg24Cys),"Melanoma, cutaneous malignant, susceptibility to, 3",Cutaneous malignant melanoma 3
CDK4,rs11547328,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Pathogenic,RCV000168188.6,12q14.1,NM_000075.4(CDK4):c.70C>T (p.Arg24Cys),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDK4,rs11547328,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Likely-Pathogenic,RCV000420489.1,12q14.1,NM_000075.4(CDK4):c.70C>T (p.Arg24Cys),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDK4,rs11547328,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Likely-Pathogenic,RCV000426326.1,12q14.1,NM_000075.4(CDK4):c.70C>T (p.Arg24Cys),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
CDK4,rs11547328,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Likely-Pathogenic,RCV000438126.1,12q14.1,NM_000075.4(CDK4):c.70C>T (p.Arg24Cys),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDK4,rs11547328,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Pathogenic,RCV000484583.1,12q14.1,NM_000075.4(CDK4):c.70C>T (p.Arg24Cys),none provided,MedGen: C3661900
CDK4,rs11547328,G,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Pathogenic,RCV000584153.3,12q14.1,NM_000075.4(CDK4):c.70C>T (p.Arg24Cys),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDK4,rs11547328,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Likely-Pathogenic,RCV000419745.1,12q14.1,NM_000075.4(CDK4):c.70C>A (p.Arg24Ser),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDK4,rs11547328,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Likely-Pathogenic,RCV000429137.1,12q14.1,NM_000075.4(CDK4):c.70C>A (p.Arg24Ser),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
CDK4,rs11547328,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/251466, GnomAD_exome).A=0.000008 (1/121378, ExAC).A=0.0000 (0/7540, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs11547328#publications,Likely-Pathogenic,RCV000437447.1,12q14.1,NM_000075.4(CDK4):c.70C>A (p.Arg24Ser),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDK4,rs104894340,C,A,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Likely-Pathogenic,RCV000427015.1,12q14.1,NM_000075.4(CDK4):c.71G>T (p.Arg24Leu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDK4,rs104894340,C,A,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Likely-Pathogenic,RCV000431833.1,12q14.1,NM_000075.4(CDK4):c.71G>T (p.Arg24Leu),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDK4,rs104894340,C,A,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Likely-Pathogenic,RCV000442117.1,12q14.1,NM_000075.4(CDK4):c.71G>T (p.Arg24Leu),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
CDK4,rs104894340,C,T,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Risk-Factor,RCV000018437.3,12q14.1,NM_000075.4(CDK4):c.71G>A (p.Arg24His),"Melanoma, cutaneous malignant, susceptibility to, 3",Cutaneous malignant melanoma 3
CDK4,rs104894340,C,T,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Likely-Pathogenic,RCV000423488.1,12q14.1,NM_000075.4(CDK4):c.71G>A (p.Arg24His),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
CDK4,rs104894340,C,T,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Likely-Pathogenic,RCV000434181.1,12q14.1,NM_000075.4(CDK4):c.71G>A (p.Arg24His),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDK4,rs104894340,C,T,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Likely-Pathogenic,RCV000442005.1,12q14.1,NM_000075.4(CDK4):c.71G>A (p.Arg24His),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDK4,rs104894340,C,T,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Likely-Pathogenic,RCV000444499.1,12q14.1,NM_000075.4(CDK4):c.71G>A (p.Arg24His),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
CDK4,rs104894340,C,T,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Pathogenic,RCV001026151.1,12q14.1,NM_000075.4(CDK4):c.71G>A (p.Arg24His),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDK4,rs104894340,C,T,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs104894340,Pathogenic,RCV001851913.1,12q14.1,NM_000075.4(CDK4):c.71G>A (p.Arg24His),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN1B,rs121917832,G,A,"upstream_transcript_variant,2KB_upstream_variant,coding_sequence_variant,stop_gained","A=0.00000 (0/78700, PAGE_STUDY).A=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121917832#publications,Pathogenic,RCV000009371.9,12p13.1,NM_004064.5(CDKN1B):c.227G>A (p.Trp76Ter),Multiple endocrine neoplasia type 4,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV"
CDKN1B,rs551236750,C,T,"5_prime_UTR_variant,upstream_transcript_variant,2KB_upstream_variant","T=0.000166 (44/264690, TOPMED).T=0.000214 (30/140300, GnomAD).T=0.00014 (2/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs551236750,Pathogenic,RCV000210356.1,12p13.1,NM_004064.5(CDKN1B):c.-80C>T,Primary hyperparathyroidism,Primary hyperthyroidism; Primary hyperparathyroidism (disease)
CDKN1B,rs774454456,AGAG,delAGAG,"2KB_upstream_variant,upstream_transcript_variant,5_prime_UTR_variant","delAGAG=0.000548 (145/264690, TOPMED).delAGAG=0.000376 (92/244842, GnomAD_exome).delAGAG=0.000392 (55/140186, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs774454456,Pathogenic,RCV000210358.1,12p13.1,NM_004064.5(CDKN1B):c.-31AG[1],Primary hyperparathyroidism,Primary hyperthyroidism; Primary hyperparathyroidism (disease)
CDKN1B,rs786201007,-,dupAGGCGGAGCA(C)4AAGCC,"frameshift_variant,coding_sequence_variant,upstream_transcript_variant,2KB_upstream_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs786201007,Pathogenic,RCV000162205.4,12p13.1,NM_004064.5(CDKN1B):c.59_77dup (p.Ser27fs),Multiple endocrine neoplasia type 4,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV"
CDKN1B,rs786201010,TTCC,delTTCC,"2KB_upstream_variant,upstream_transcript_variant,5_prime_UTR_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs786201010,Pathogenic,RCV000162208.4,12p13.1,NM_004064.5(CDKN1B):c.-454_-451del,Multiple endocrine neoplasia type 4,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV"
CDKN1B,rs786201011,CT,delCT,"stop_gained,coding_sequence_variant,upstream_transcript_variant,2KB_upstream_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs786201011,Pathogenic,RCV000162209.5,12p13.1,NM_004064.5(CDKN1B):c.374_375del (p.Asn124_Ser125insTer),Multiple endocrine neoplasia type 4,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV"
CDKN1B,rs797044481,C,delCinsTAA,"2KB_upstream_variant,upstream_transcript_variant,coding_sequence_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs797044481,Likely-Pathogenic,RCV000191951.1,12p13.1,NM_004064.5(CDKN1B):c.127delinsTAA (p.Arg43Ter),Neuroendocrine neoplasm,MONDO: MONDO:0019496; MedGen: C0206754; Human Phenotype Ontology: HP:0100634
CDKN1B,rs797044482,-,insT,"2KB_upstream_variant,upstream_transcript_variant,coding_sequence_variant,frameshift_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs797044482,Likely-Pathogenic,RCV000191952.1,12p13.1,NM_004064.5(CDKN1B):c.279_280insT (p.Pro94fs),Neuroendocrine neoplasm,MONDO: MONDO:0019496; MedGen: C0206754; Human Phenotype Ontology: HP:0100634
CDKN1B,rs797044483,A,delA,"2KB_upstream_variant,upstream_transcript_variant,coding_sequence_variant,frameshift_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs797044483,Likely-Pathogenic,RCV000191953.1,12p13.1,NM_004064.5(CDKN1B):c.334del (p.Ser112fs),Neuroendocrine neoplasm,MONDO: MONDO:0019496; MedGen: C0206754; Human Phenotype Ontology: HP:0100634
CDKN1B,rs774454456,AGAG,delAGAG,"2KB_upstream_variant,upstream_transcript_variant,5_prime_UTR_variant","delAGAG=0.000548 (145/264690, TOPMED).delAGAG=0.000376 (92/244842, GnomAD_exome).delAGAG=0.000392 (55/140186, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs774454456,Pathogenic,RCV000210358.1,12p13.1,NM_004064.5(CDKN1B):c.-31AG[1],Primary hyperparathyroidism,Primary hyperthyroidism; Primary hyperparathyroidism (disease)
CDKN1C,rs104894200,G,T,"coding_sequence_variant,intron_variant,stop_gained,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs104894200#publications,Pathogenic,RCV000009290.6,11p15.4,NM_001122630.2(CDKN1C):c.707C>A (p.Ser236Ter),"Beckwith-Wiedemann syndrome (BWS)
                    ",Exomphalos macroglossia gigantism syndrome; EMG Syndrome
CDKN1C,rs267606716,G,C,"stop_gained,missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs267606716,Pathogenic,RCV000009291.3,11p15.4,NM_001122630.2(CDKN1C):c.812C>G (p.Ser271Ter),"Beckwith-Wiedemann syndrome (BWS)
                    ",Exomphalos macroglossia gigantism syndrome; EMG Syndrome
CDKN1C,rs267606716,G,C,"stop_gained,missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs267606716,Likely-Pathogenic,RCV000521869.2,11p15.4,NM_001122630.2(CDKN1C):c.812C>G (p.Ser271Ter),none provided,MedGen: CN517202
CDKN1C,rs267606716,G,T,"stop_gained,missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs267606716,Pathogenic,RCV000009292.4,11p15.4,NM_001122630.2(CDKN1C):c.812C>A (p.Ser271Ter),"Beckwith-Wiedemann syndrome (BWS)
                    ",Exomphalos macroglossia gigantism syndrome; EMG Syndrome
CDKN1C,rs318240750,C,A,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs318240750,Pathogenic,RCV000240673.3,11p15.4,NM_001122630.2(CDKN1C):c.803G>T (p.Arg268Leu),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN1C,rs318240750,C,G,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs318240750,Pathogenic,RCV000029185.6,11p15.4,NM_001122630.2(CDKN1C):c.803G>C (p.Arg268Pro),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN1C,rs387907223,A,C,"synonymous_variant,missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs387907223,Pathogenic,RCV000029183.6,11p15.4,NM_001122630.2(CDKN1C):c.793T>G (p.Phe265Val),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN1C,rs387907224,A,G,"missense_variant,coding_sequence_variant","G=0.001 (1/782, PRJEB37584)",1,https://www.ncbi.nlm.nih.gov/snp/rs387907224,Pathogenic,RCV000029184.6,11p15.4,NM_001122630.2(CDKN1C):c.794T>C (p.Phe265Ser),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN1C,rs387907224,A,G,"missense_variant,coding_sequence_variant","G=0.001 (1/782, PRJEB37584)",1,https://www.ncbi.nlm.nih.gov/snp/rs387907224,Likely-Pathogenic,RCV001596942.2,11p15.4,NM_001122630.2(CDKN1C):c.794T>C (p.Phe265Ser),none provided,MedGen: CN517202
CDKN1C,rs387907225,C,T,"missense_variant,coding_sequence_variant,intron_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387907225,Pathogenic,RCV000029186.4,11p15.4,NM_001122630.2(CDKN1C):c.787G>A (p.Asp263Asn),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN1C,rs387907225,C,T,"missense_variant,coding_sequence_variant,intron_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387907225,Pathogenic,RCV001380060.4,11p15.4,NM_001122630.2(CDKN1C):c.787G>A (p.Asp263Asn),"Beckwith-Wiedemann syndrome (BWS)
                    ",Exomphalos macroglossia gigantism syndrome; EMG Syndrome
CDKN1C,rs387907226,T,C,"synonymous_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs387907226,Pathogenic,RCV000029187.6,11p15.4,NM_001122630.2(CDKN1C):c.799A>G (p.Lys267Glu),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN1C,rs515726203,A,C,"missense_variant,coding_sequence_variant,intron_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs515726203,Pathogenic,RCV000119018.3,11p15.4,NM_001122630.2(CDKN1C):c.782T>G (p.Ile261Ser),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN1C,rs886037912,C,A,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs886037912,Pathogenic,RCV000240658.2,11p15.4,NM_001122630.2(CDKN1C):c.809G>T (p.Arg270Ile),IMAGe syndrome,"Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies"
CDKN2A,rs6413464,C,G,"3_prime_UTR_variant,coding_sequence_variant,missense_variant","A=0.006105 (1616/264690, TOPMED).A=0.005267 (739/140298, GnomAD).A=0.00129 (91/70772, ALFA)",11,https://www.ncbi.nlm.nih.gov/snp/rs6413464#publications,Likely-Pathogenic,RCV001021177.4,9p21.3,NM_000077.5(CDKN2A):c.379G>C (p.Ala127Pro),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs11552822,C,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.000004 (1/231524, GnomAD_exome).G=0.00004 (1/28258, 14KJPN).G=0.00006 (1/16760, 8.3KJPN)",2,https://www.ncbi.nlm.nih.gov/snp/rs11552822,Likely-Pathogenic,RCV000419046.1,9p21.3,NM_000077.5(CDKN2A):c.250G>T (p.Asp84Tyr),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs11552822,C,T,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.000004 (1/231524, GnomAD_exome).G=0.00004 (1/28258, 14KJPN).G=0.00006 (1/16760, 8.3KJPN)",2,https://www.ncbi.nlm.nih.gov/snp/rs11552822,Likely-Pathogenic,RCV000988153.2,9p21.3,NM_000077.5(CDKN2A):c.250G>A (p.Asp84Asn),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000422116.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),Gastric adenocarcinoma,Adenocarcinoma of stomach
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000422956.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000423602.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000431254.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000432376.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000433889.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000441491.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
CDKN2A,rs34968276,G,C,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Likely-Pathogenic,RCV000443430.1,9p21.3,NM_000077.5(CDKN2A):c.249C>G (p.His83Gln),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs34968276,G,T,"3_prime_UTR_variant,stop_gained,coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs34968276,Pathogenic,RCV000493314.3,9p21.3,NM_000077.5(CDKN2A):c.249C>A (p.His83Gln),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894094,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000007 (1/140294, GnomAD).G=0.000018 (2/110970, ExAC).A=0.00003 (1/33992, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894094,Pathogenic,RCV000010018.3,9p21.3,NM_000077.5(CDKN2A):c.301G>T (p.Gly101Trp),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs104894094,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000007 (1/140294, GnomAD).G=0.000018 (2/110970, ExAC).A=0.00003 (1/33992, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894094,Pathogenic,RCV000010019.5,9p21.3,NM_000077.5(CDKN2A):c.301G>T (p.Gly101Trp),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs104894094,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000007 (1/140294, GnomAD).G=0.000018 (2/110970, ExAC).A=0.00003 (1/33992, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894094,Pathogenic,RCV000115334.14,9p21.3,NM_000077.5(CDKN2A):c.301G>T (p.Gly101Trp),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894094,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000007 (1/140294, GnomAD).G=0.000018 (2/110970, ExAC).A=0.00003 (1/33992, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894094,Pathogenic,RCV000196633.12,9p21.3,NM_000077.5(CDKN2A):c.301G>T (p.Gly101Trp),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs104894094,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000007 (1/140294, GnomAD).G=0.000018 (2/110970, ExAC).A=0.00003 (1/33992, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894094,Pathogenic,RCV000212400.18,9p21.3,NM_000077.5(CDKN2A):c.301G>T (p.Gly101Trp),none provided,MedGen: CN517202
CDKN2A,rs104894094,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000007 (1/140294, GnomAD).G=0.000018 (2/110970, ExAC).A=0.00003 (1/33992, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894094,Pathogenic,RCV000415140.1,9p21.3,NM_000077.5(CDKN2A):c.301G>T (p.Gly101Trp),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
CDKN2A,rs104894094,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000007 (1/140294, GnomAD).G=0.000018 (2/110970, ExAC).A=0.00003 (1/33992, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894094,Pathogenic,RCV000622260.1,9p21.3,NM_000077.5(CDKN2A):c.301G>T (p.Gly101Trp),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
CDKN2A,rs104894095,C,G,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000009 (2/221078, GnomAD_exome).G=0.000007 (1/140290, GnomAD)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894095,Risk-Factor,RCV000010021.3,9p21.3,NM_000077.5(CDKN2A):c.159G>C (p.Met53Ile),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs104894095,C,G,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000009 (2/221078, GnomAD_exome).G=0.000007 (1/140290, GnomAD)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894095,Pathogenic,RCV000160421.7,9p21.3,NM_000077.5(CDKN2A):c.159G>C (p.Met53Ile),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894095,C,G,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000009 (2/221078, GnomAD_exome).G=0.000007 (1/140290, GnomAD)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894095,Pathogenic,RCV000205342.9,9p21.3,NM_000077.5(CDKN2A):c.159G>C (p.Met53Ile),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs104894095,C,G,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000009 (2/221078, GnomAD_exome).G=0.000007 (1/140290, GnomAD)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894095,Pathogenic,RCV000212399.6,9p21.3,NM_000077.5(CDKN2A):c.159G>C (p.Met53Ile),none provided,MedGen: CN517202
CDKN2A,rs104894095,C,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000009 (2/221078, GnomAD_exome).G=0.000007 (1/140290, GnomAD)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894095,Pathogenic,RCV000638996.4,9p21.3,NM_000077.5(CDKN2A):c.159G>A (p.Met53Ile),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs104894095,C,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","G=0.000011 (3/264690, TOPMED).G=0.000009 (2/221078, GnomAD_exome).G=0.000007 (1/140290, GnomAD)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894095,Pathogenic-Likely-Pathogenic,RCV001012299.2,9p21.3,NM_000077.5(CDKN2A):c.159G>A (p.Met53Ile),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894097,C,G,"genic_upstream_transcript_variant,missense_variant,intron_variant,coding_sequence_variant","G=0.000014 (2/140104, GnomAD).T=0.00008 (3/35782, ALFA)",13,https://www.ncbi.nlm.nih.gov/snp/rs104894097,Risk-Factor,RCV000010022.2,9p21.3,NM_000077.5(CDKN2A):c.71G>C (p.Arg24Pro),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs104894097,C,G,"genic_upstream_transcript_variant,missense_variant,intron_variant,coding_sequence_variant","G=0.000014 (2/140104, GnomAD).T=0.00008 (3/35782, ALFA)",13,https://www.ncbi.nlm.nih.gov/snp/rs104894097,Pathogenic,RCV000167312.10,9p21.3,NM_000077.5(CDKN2A):c.71G>C (p.Arg24Pro),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894097,C,G,"genic_upstream_transcript_variant,missense_variant,intron_variant,coding_sequence_variant","G=0.000014 (2/140104, GnomAD).T=0.00008 (3/35782, ALFA)",13,https://www.ncbi.nlm.nih.gov/snp/rs104894097,Pathogenic,RCV000236320.3,9p21.3,NM_000077.5(CDKN2A):c.71G>C (p.Arg24Pro),none provided,MedGen: CN517202
CDKN2A,rs104894097,C,G,"genic_upstream_transcript_variant,missense_variant,intron_variant,coding_sequence_variant","G=0.000014 (2/140104, GnomAD).T=0.00008 (3/35782, ALFA)",13,https://www.ncbi.nlm.nih.gov/snp/rs104894097,Pathogenic-Likely-Pathogenic,RCV000410204.3,9p21.3,NM_000077.5(CDKN2A):c.71G>C (p.Arg24Pro),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs104894097,C,G,"genic_upstream_transcript_variant,missense_variant,intron_variant,coding_sequence_variant","G=0.000014 (2/140104, GnomAD).T=0.00008 (3/35782, ALFA)",13,https://www.ncbi.nlm.nih.gov/snp/rs104894097,Pathogenic,RCV000472219.8,9p21.3,NM_000077.5(CDKN2A):c.71G>C (p.Arg24Pro),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs104894097,C,G,"genic_upstream_transcript_variant,missense_variant,intron_variant,coding_sequence_variant","G=0.000014 (2/140104, GnomAD).T=0.00008 (3/35782, ALFA)",13,https://www.ncbi.nlm.nih.gov/snp/rs104894097,Pathogenic,RCV000763193.1,9p21.3,NM_000077.5(CDKN2A):c.71G>C (p.Arg24Pro),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs104894098,A,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).T=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894098,Risk-Factor,RCV000010027.3,9p21.3,NM_000077.5(CDKN2A):c.377T>A (p.Val126Asp),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs104894098,A,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).T=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894098,Pathogenic,RCV000160413.8,9p21.3,NM_000077.5(CDKN2A):c.377T>A (p.Val126Asp),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894098,A,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).T=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894098,Pathogenic,RCV000212403.4,9p21.3,NM_000077.5(CDKN2A):c.377T>A (p.Val126Asp),none provided,MedGen: CN517202
CDKN2A,rs104894098,A,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).T=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894098,Pathogenic,RCV000227154.9,9p21.3,NM_000077.5(CDKN2A):c.377T>A (p.Val126Asp),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs104894098,A,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).T=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894098,Pathogenic,RCV000576733.2,9p21.3,NM_000077.5(CDKN2A):c.377T>A (p.Val126Asp),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs104894099,A,C,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant","C=0.000011 (3/264690, TOPMED).C=0.000005 (1/219096, GnomAD_exome).C=0.00001 (1/83030, ExAC)",10,https://www.ncbi.nlm.nih.gov/snp/rs104894099,Risk-Factor,RCV000010030.4,9p21.3,NM_000077.5(CDKN2A):c.176T>G (p.Val59Gly),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs104894099,A,C,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant","C=0.000011 (3/264690, TOPMED).C=0.000005 (1/219096, GnomAD_exome).C=0.00001 (1/83030, ExAC)",10,https://www.ncbi.nlm.nih.gov/snp/rs104894099,Likely-Pathogenic,RCV000409228.1,9p21.3,NM_000077.5(CDKN2A):c.176T>G (p.Val59Gly),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs104894099,A,C,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant","C=0.000011 (3/264690, TOPMED).C=0.000005 (1/219096, GnomAD_exome).C=0.00001 (1/83030, ExAC)",10,https://www.ncbi.nlm.nih.gov/snp/rs104894099,Likely-Pathogenic,RCV000494082.6,9p21.3,NM_000077.5(CDKN2A):c.176T>G (p.Val59Gly),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894099,A,C,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant","C=0.000011 (3/264690, TOPMED).C=0.000005 (1/219096, GnomAD_exome).C=0.00001 (1/83030, ExAC)",10,https://www.ncbi.nlm.nih.gov/snp/rs104894099,Pathogenic,RCV000545232.6,9p21.3,NM_000077.5(CDKN2A):c.176T>G (p.Val59Gly),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs104894099,A,C,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant","C=0.000011 (3/264690, TOPMED).C=0.000005 (1/219096, GnomAD_exome).C=0.00001 (1/83030, ExAC)",10,https://www.ncbi.nlm.nih.gov/snp/rs104894099,Pathogenic,RCV001800291.1,9p21.3,NM_000077.5(CDKN2A):c.176T>G (p.Val59Gly),none provided,MedGen: CN517202
CDKN2A,rs104894104,G,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","A=0.0002 (1/6404, 1000G_30x).A=0.0002 (1/5008, 1000G)",1,https://www.ncbi.nlm.nih.gov/snp/rs104894104,Likely-Pathogenic,RCV000420288.1,9p21.3,NM_000077.5(CDKN2A):c.340C>A (p.Pro114Thr),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs104894104,G,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","A=0.0002 (1/6404, 1000G_30x).A=0.0002 (1/5008, 1000G)",1,https://www.ncbi.nlm.nih.gov/snp/rs104894104,Likely-Pathogenic,RCV000425046.1,9p21.3,NM_000077.5(CDKN2A):c.340C>A (p.Pro114Thr),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs104894104,G,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","A=0.0002 (1/6404, 1000G_30x).A=0.0002 (1/5008, 1000G)",1,https://www.ncbi.nlm.nih.gov/snp/rs104894104,Likely-Pathogenic,RCV000430525.1,9p21.3,NM_000077.5(CDKN2A):c.340C>A (p.Pro114Thr),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
CDKN2A,rs104894104,G,T,"3_prime_UTR_variant,missense_variant,coding_sequence_variant","A=0.0002 (1/6404, 1000G_30x).A=0.0002 (1/5008, 1000G)",1,https://www.ncbi.nlm.nih.gov/snp/rs104894104,Likely-Pathogenic,RCV000435329.1,9p21.3,NM_000077.5(CDKN2A):c.340C>A (p.Pro114Thr),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs104894109,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs104894109,Risk-Factor,RCV000010032.3,9p21.3,NM_000077.5(CDKN2A):c.167G>T (p.Ser56Ile),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs104894109,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs104894109,Pathogenic,RCV000471463.6,9p21.3,NM_000077.5(CDKN2A):c.167G>T (p.Ser56Ile),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs104894109,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs104894109,Pathogenic,RCV000573952.2,9p21.3,NM_000077.5(CDKN2A):c.167G>T (p.Ser56Ile),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs104894109,C,A,"3_prime_UTR_variant,missense_variant,coding_sequence_variant,synonymous_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs104894109,Likely-Pathogenic,RCV000759745.3,9p21.3,NM_000077.5(CDKN2A):c.167G>T (p.Ser56Ile),none provided,MedGen: C3661900
CDKN2A,rs113798404,C,G,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs113798404,Risk-Factor,RCV000010029.2,9p21.3,NM_000077.5(CDKN2A):c.364G>C (p.Gly122Arg),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs121913381,C,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913381,Likely-Pathogenic,RCV000160422.5,9p21.3,NM_000077.5(CDKN2A):c.322G>T (p.Asp108Tyr),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs121913381,C,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913381,Likely-Pathogenic,RCV000425594.1,9p21.3,NM_000077.5(CDKN2A):c.322G>T (p.Asp108Tyr),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs121913382,C,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,stop_gained","T=0.000005 (1/218460, GnomAD_exome)",1,https://www.ncbi.nlm.nih.gov/snp/rs121913382,Likely-Pathogenic,RCV000419719.1,9p21.3,NM_000077.5(CDKN2A):c.181G>T (p.Glu61Ter),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs121913383,C,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913383,Likely-Pathogenic,RCV000436921.1,9p21.3,NM_000077.5(CDKN2A):c.205G>T (p.Glu69Ter),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs121913384,C,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913384,Likely-Pathogenic,RCV000436299.1,9p21.3,NM_000077.5(CDKN2A):c.262G>T (p.Glu88Ter),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs121913384,C,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913384,Pathogenic,RCV001184202.2,9p21.3,NM_000077.5(CDKN2A):c.262G>T (p.Glu88Ter),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000419112.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000421013.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000423848.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000426295.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000429387.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000432117.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),Gastric adenocarcinoma,Adenocarcinoma of stomach
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000438754.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000438919.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs121913385,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000439424.1,9p21.3,NM_000077.5(CDKN2A):c.247C>T (p.His83Tyr),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000418136.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000418718.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000425239.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000428114.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000428379.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000434935.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000436374.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),Gastric adenocarcinoma,Adenocarcinoma of stomach
CDKN2A,rs121913385,G,C,"coding_sequence_variant,3_prime_UTR_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913385,Likely-Pathogenic,RCV000441259.1,9p21.3,NM_000077.5(CDKN2A):c.247C>G (p.His83Asp),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs121913386,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000424989.1,9p21.3,NM_000077.5(CDKN2A):c.341C>T (p.Pro114Leu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
CDKN2A,rs121913386,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000425751.1,9p21.3,NM_000077.5(CDKN2A):c.341C>T (p.Pro114Leu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs121913386,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000435136.1,9p21.3,NM_000077.5(CDKN2A):c.341C>T (p.Pro114Leu),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
CDKN2A,rs121913386,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000442671.1,9p21.3,NM_000077.5(CDKN2A):c.341C>T (p.Pro114Leu),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs121913386,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000444494.1,9p21.3,NM_000077.5(CDKN2A):c.341C>T (p.Pro114Leu),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs121913386,G,A,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Pathogenic,RCV000569438.2,9p21.3,NM_000077.5(CDKN2A):c.341C>T (p.Pro114Leu),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs121913386,G,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000420475.1,9p21.3,NM_000077.5(CDKN2A):c.341C>A (p.Pro114His),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs121913386,G,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000429868.1,9p21.3,NM_000077.5(CDKN2A):c.341C>A (p.Pro114His),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs121913386,G,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000438111.1,9p21.3,NM_000077.5(CDKN2A):c.341C>A (p.Pro114His),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
CDKN2A,rs121913386,G,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913386,Likely-Pathogenic,RCV000440098.1,9p21.3,NM_000077.5(CDKN2A):c.341C>A (p.Pro114His),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs121913387,G,A,"3_prime_UTR_variant,missense_variant,synonymous_variant,coding_sequence_variant,stop_gained","C=0.000005 (1/219734, GnomAD_exome)",1,https://www.ncbi.nlm.nih.gov/snp/rs121913387,Likely-Pathogenic,RCV000430418.1,9p21.3,NM_000077.5(CDKN2A):c.172C>T (p.Arg58Ter),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs121913387,G,A,"3_prime_UTR_variant,missense_variant,synonymous_variant,coding_sequence_variant,stop_gained","C=0.000005 (1/219734, GnomAD_exome)",1,https://www.ncbi.nlm.nih.gov/snp/rs121913387,Pathogenic,RCV000638957.6,9p21.3,NM_000077.5(CDKN2A):c.172C>T (p.Arg58Ter),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs121913388,G,A,"3_prime_UTR_variant,missense_variant,synonymous_variant,coding_sequence_variant,stop_gained","C=0.000004 (1/229380, GnomAD_exome).C=0.000009 (1/106328, ExAC)",3,https://www.ncbi.nlm.nih.gov/snp/rs121913388,Risk-Factor,RCV000010012.2,9p21.3,NM_000077.5(CDKN2A):c.238C>T (p.Arg80Ter),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs121913388,G,A,"3_prime_UTR_variant,missense_variant,synonymous_variant,coding_sequence_variant,stop_gained","C=0.000004 (1/229380, GnomAD_exome).C=0.000009 (1/106328, ExAC)",3,https://www.ncbi.nlm.nih.gov/snp/rs121913388,Likely-Pathogenic,RCV000429694.1,9p21.3,NM_000077.5(CDKN2A):c.238C>T (p.Arg80Ter),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
CDKN2A,rs121913388,G,A,"3_prime_UTR_variant,missense_variant,synonymous_variant,coding_sequence_variant,stop_gained","C=0.000004 (1/229380, GnomAD_exome).C=0.000009 (1/106328, ExAC)",3,https://www.ncbi.nlm.nih.gov/snp/rs121913388,Pathogenic,RCV001186483.2,9p21.3,NM_000077.5(CDKN2A):c.238C>T (p.Arg80Ter),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs121913388,G,A,"3_prime_UTR_variant,missense_variant,synonymous_variant,coding_sequence_variant,stop_gained","C=0.000004 (1/229380, GnomAD_exome).C=0.000009 (1/106328, ExAC)",3,https://www.ncbi.nlm.nih.gov/snp/rs121913388,Pathogenic,RCV001255666.1,9p21.3,NM_000077.5(CDKN2A):c.238C>T (p.Arg80Ter),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
CDKN2A,rs121913388,G,A,"3_prime_UTR_variant,missense_variant,synonymous_variant,coding_sequence_variant,stop_gained","C=0.000004 (1/229380, GnomAD_exome).C=0.000009 (1/106328, ExAC)",3,https://www.ncbi.nlm.nih.gov/snp/rs121913388,Pathogenic-Likely-Pathogenic,RCV001588807.5,9p21.3,NM_000077.5(CDKN2A):c.238C>T (p.Arg80Ter),none provided,MedGen: CN517202
CDKN2A,rs121913389,C,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913389,Likely-Pathogenic,RCV000432172.1,9p21.3,NM_000077.5(CDKN2A):c.330G>A (p.Trp110Ter),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs121913389,C,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913389,Pathogenic,RCV001255669.1,9p21.3,NM_000077.5(CDKN2A):c.330G>A (p.Trp110Ter),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
CDKN2A,rs137854597,C,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant","T=0.000004 (1/233080, GnomAD_exome).T=0.000009 (1/110026, ExAC).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs137854597,Risk-Factor,RCV000010011.2,9p21.3,NM_000077.5(CDKN2A):c.265G>A (p.Gly89Ser),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs137854599,C,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs137854599,Risk-Factor,RCV000010033.4,9p21.3,NM_000077.5(CDKN2A):c.266G>A (p.Gly89Asp),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs137854599,C,T,"coding_sequence_variant,3_prime_UTR_variant,missense_variant,synonymous_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs137854599,Pathogenic,RCV000493646.2,9p21.3,NM_000077.5(CDKN2A):c.266G>A (p.Gly89Asp),none provided,MedGen: C3661900
CDKN2A,rs199907548,A,C,"coding_sequence_variant,genic_upstream_transcript_variant,intron_variant,missense_variant","G=0.000298 (79/264690, TOPMED).G=0.000625 (156/249454, GnomAD_exome).G=0.000064 (9/140198, GnomAD)",8,https://www.ncbi.nlm.nih.gov/snp/rs199907548,Likely-Pathogenic,RCV000493292.1,9p21.3,NM_000077.5(CDKN2A):c.146T>G (p.Ile49Ser),none provided,MedGen: C3661900
CDKN2A,rs199907548,A,C,"coding_sequence_variant,genic_upstream_transcript_variant,intron_variant,missense_variant","G=0.000298 (79/264690, TOPMED).G=0.000625 (156/249454, GnomAD_exome).G=0.000064 (9/140198, GnomAD)",8,https://www.ncbi.nlm.nih.gov/snp/rs199907548,Likely-Pathogenic,RCV000528787.3,9p21.3,NM_000077.5(CDKN2A):c.146T>G (p.Ile49Ser),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs199907548,A,C,"coding_sequence_variant,genic_upstream_transcript_variant,intron_variant,missense_variant","G=0.000298 (79/264690, TOPMED).G=0.000625 (156/249454, GnomAD_exome).G=0.000064 (9/140198, GnomAD)",8,https://www.ncbi.nlm.nih.gov/snp/rs199907548,Pathogenic,RCV002272262.1,9p21.3,NM_000077.5(CDKN2A):c.146T>G (p.Ile49Ser),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs199907548,A,G,"coding_sequence_variant,genic_upstream_transcript_variant,intron_variant,missense_variant","G=0.000298 (79/264690, TOPMED).G=0.000625 (156/249454, GnomAD_exome).G=0.000064 (9/140198, GnomAD)",8,https://www.ncbi.nlm.nih.gov/snp/rs199907548,Likely-Pathogenic,RCV000122945.12,9p21.3,NM_000077.5(CDKN2A):c.146T>C (p.Ile49Thr),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs199907548,A,G,"coding_sequence_variant,genic_upstream_transcript_variant,intron_variant,missense_variant","G=0.000298 (79/264690, TOPMED).G=0.000625 (156/249454, GnomAD_exome).G=0.000064 (9/140198, GnomAD)",8,https://www.ncbi.nlm.nih.gov/snp/rs199907548,Likely-Pathogenic,RCV001292944.1,9p21.3,NM_000077.5(CDKN2A):c.146T>C (p.Ile49Thr),Melanoma and neural system tumor syndrome,Melanoma astrocytoma syndrome
CDKN2A,rs387906410,GC,AG,"3_prime_UTR_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387906410,Risk-Factor,RCV000010031.3,9p21.3,NM_000077.5(CDKN2A):c.339_340delinsCT (p.Pro114Ser),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs387906410,GC,AG,"3_prime_UTR_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387906410,Pathogenic,RCV000160409.2,9p21.3,NM_000077.5(CDKN2A):c.339_340delinsCT (p.Pro114Ser),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000213788.6,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000424913.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000427856.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),Gastric adenocarcinoma,Adenocarcinoma of stomach
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000431578.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000437789.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000438067.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000442170.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000442244.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000471227.4,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs587778189,T,C,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV002222452.1,9p21.3,NM_000077.5(CDKN2A):c.149A>G (p.Gln50Arg),none provided,MedGen: CN517202
CDKN2A,rs587778189,T,G,"missense_variant,genic_upstream_transcript_variant,intron_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.00000 (0/10680, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs587778189,Likely-Pathogenic,RCV000167463.2,9p21.3,NM_000077.5(CDKN2A):c.149A>C (p.Gln50Pro),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Risk-Factor,RCV000010023.6,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Likely-Pathogenic,RCV000122949.11,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Pathogenic-Likely-Pathogenic,RCV000160401.9,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),none provided,MedGen: CN517202
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Pathogenic-Likely-Pathogenic,RCV000163609.11,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs1057519852,C,T,"synonymous_variant,3_prime_UTR_variant,coding_sequence_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519852,Likely-Pathogenic,RCV000445033.1,9p21.3,NM_000077.5(CDKN2A):c.329G>A (p.Trp110Ter),Neoplasm,Neoplasms; Neoplasm (disease)
CDKN2A,rs1057519852,C,T,"synonymous_variant,3_prime_UTR_variant,coding_sequence_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519852,Pathogenic,RCV000657726.1,9p21.3,NM_000077.5(CDKN2A):c.329G>A (p.Trp110Ter),none provided,MedGen: C3661900
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000418529.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000426834.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000427609.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000433507.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000434118.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000437058.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),Gastric adenocarcinoma,Adenocarcinoma of stomach
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000442368.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Likely-Pathogenic,RCV000442465.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
CDKN2A,rs1057519881,T,C,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","C=0.0002 (1/6404, 1000G_30x)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519881,Pathogenic,RCV001310110.1,9p21.3,NM_000077.5(CDKN2A):c.248A>G (p.His83Arg),Melanoma-pancreatic cancer syndrome,MONDO: MONDO:0011713; MedGen: C1838547; Orphanet: 404560; OMIM: 606719
CDKN2A,rs1057519882,C,A,"coding_sequence_variant,missense_variant,synonymous_variant,intron_variant,genic_upstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519882,Likely-Pathogenic,RCV000421337.1,9p21.3,NM_000077.5(CDKN2A):c.150G>T (p.Gln50His),Gastric adenocarcinoma,Adenocarcinoma of stomach
CDKN2A,rs1057519882,C,A,"coding_sequence_variant,missense_variant,synonymous_variant,intron_variant,genic_upstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519882,Likely-Pathogenic,RCV000421945.1,9p21.3,NM_000077.5(CDKN2A):c.150G>T (p.Gln50His),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs1057519882,C,A,"coding_sequence_variant,missense_variant,synonymous_variant,intron_variant,genic_upstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519882,Likely-Pathogenic,RCV000423473.1,9p21.3,NM_000077.5(CDKN2A):c.150G>T (p.Gln50His),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
CDKN2A,rs1057519882,C,A,"coding_sequence_variant,missense_variant,synonymous_variant,intron_variant,genic_upstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519882,Likely-Pathogenic,RCV000430232.1,9p21.3,NM_000077.5(CDKN2A):c.150G>T (p.Gln50His),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
CDKN2A,rs1057519882,C,A,"coding_sequence_variant,missense_variant,synonymous_variant,intron_variant,genic_upstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519882,Likely-Pathogenic,RCV000433093.1,9p21.3,NM_000077.5(CDKN2A):c.150G>T (p.Gln50His),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
CDKN2A,rs1057519882,C,A,"coding_sequence_variant,missense_variant,synonymous_variant,intron_variant,genic_upstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519882,Likely-Pathogenic,RCV000439595.1,9p21.3,NM_000077.5(CDKN2A):c.150G>T (p.Gln50His),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs1057519882,C,A,"coding_sequence_variant,missense_variant,synonymous_variant,intron_variant,genic_upstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519882,Likely-Pathogenic,RCV000442947.1,9p21.3,NM_000077.5(CDKN2A):c.150G>T (p.Gln50His),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000418516.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000418706.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000419517.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Gastric adenocarcinoma,Adenocarcinoma of stomach
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000421584.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000426306.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),"Papillary renal cell carcinoma, sporadic",MeSH: C538614; MedGen: C1336078
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000428098.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000428790.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000431877.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000437073.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Prostate adenocarcinoma,Adenocarcinoma of prostate
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000438349.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
CDKN2A,rs1057519883,C,T,"missense_variant,3_prime_UTR_variant,coding_sequence_variant,synonymous_variant","G=0.000007 (1/140264, GnomAD).G=0.00000 (0/10680, ALFA).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519883,Likely-Pathogenic,RCV000439922.1,9p21.3,NM_000077.5(CDKN2A):c.239G>A (p.Arg80Gln),Carcinoma of esophagus,Oesophageal carcinoma; Esophageal carcinoma
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Risk-Factor,RCV000010023.6,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Likely-Pathogenic,RCV000122949.11,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Pathogenic-Likely-Pathogenic,RCV000160401.9,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),none provided,MedGen: CN517202
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Pathogenic-Likely-Pathogenic,RCV000163609.11,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Risk-Factor,RCV000010023.6,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),"Melanoma, cutaneous malignant, susceptibility to, 2",Cutaneous malignant melanoma 2
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Likely-Pathogenic,RCV000122949.11,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),Familial melanoma,Hereditary melanoma; Hereditary cutaneous melanoma
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Pathogenic-Likely-Pathogenic,RCV000160401.9,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),none provided,MedGen: CN517202
CDKN2A,rs587780668,GGCTCCATGCTGCTCCCCGCCGCC,dupGGCTCCA(TGC)2T(C)4(GCC)2,"inframe_deletion,initiator_codon_variant,inframe_insertion,genic_upstream_transcript_variant,5_prime_UTR_variant,intron_variant","delGGCTCCA(TGC)2T(C)4(GCC)2=0.000155 (41/264690, TOPMED).delGGCTCCA(TGC)2T(C)4(GCC)2=0.000065 (7/107436, ExAC).delGGCTCCA(TGC)2T(C)4(GCC)2=0.00007 (2/28258, 14KJPN)",7,https://www.ncbi.nlm.nih.gov/snp/rs587780668,Pathogenic-Likely-Pathogenic,RCV000163609.11,9p21.3,NM_000077.5(CDKN2A):c.-16GGCGGCGGGGAGCAGCATGGAGCC[3] (p.Ala4_Pro11dup),Hereditary cancer-predisposing syndrome,"Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]"
CEBPA,rs28931590,T,A,"upstream_transcript_variant,2KB_upstream_variant,missense_variant,coding_sequence_variant,5_prime_UTR_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs28931590#publications,Pathogenic,RCV000019128.7,19q13.11,NM_004364.5(CEBPA):c.251A>T (p.His84Leu),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
CEP57,rs387906977,C,T,"synonymous_variant,genic_upstream_transcript_variant,coding_sequence_variant,stop_gained","T=0.000008 (1/121308, ExAC).T=0.00000 (0/78168, PAGE_STUDY).A=0.0001 (1/9648, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387906977#publications,Pathogenic,RCV000023670.8,11q21,NM_014679.5(CEP57):c.241C>T (p.Arg81Ter),"Mosaic variegated aneuploidy syndrome 2 (MVA2)
                    ",MONDO: MONDO:0013582; MedGen: C3279843; Orphanet: 1052; OMIM: 614114
CEP57,rs577173144,G,C,"coding_sequence_variant,genic_upstream_transcript_variant,missense_variant","A=0.000007 (1/140190, GnomAD).A=0.000025 (3/120862, ExAC).A=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs577173144,Likely-Pathogenic,RCV000171200.1,11q21,NM_014679.5(CEP57):c.89G>C (p.Arg30Pro),none provided,MedGen: CN517202
